These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 15220251)

  • 1. Quinapril, an ACE inhibitor, reduces markers of oxidative stress in the metabolic syndrome.
    Khan BV; Sola S; Lauten WB; Natarajan R; Hooper WC; Menon RG; Lerakis S; Helmy T
    Diabetes Care; 2004 Jul; 27(7):1712-5. PubMed ID: 15220251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of quinapril in the presence of a weight loss regimen: endothelial function and markers of obesity in patients with the metabolic syndrome.
    Nagamia S; Pandian A; Cheema F; Natarajan R; Khan QA; Patel AD; Merchant N; Sola S; Khan BV
    Prev Cardiol; 2007; 10(4):204-9. PubMed ID: 17917517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of angiotensin-converting enzyme inhibition on transient ischemia: the Quinapril Anti-Ischemia and Symptoms of Angina Reduction (QUASAR) trial.
    Pepine CJ; Rouleau JL; Annis K; Ducharme A; Ma P; Lenis J; Davies R; Thadani U; Chaitman B; Haber HE; Freedman SB; Pressler ML; Pitt B;
    J Am Coll Cardiol; 2003 Dec; 42(12):2049-59. PubMed ID: 14680725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular effects of quinapril completely depend on ACE insertion/deletion polymorphism.
    Voors AA; van Geel PP; Oosterga M; Buikema H; van Veldhuisen DJ; van Gilst WH
    J Renin Angiotensin Aldosterone Syst; 2004 Sep; 5(3):130-4. PubMed ID: 15526248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haemodynamic response and pharmacokinetics after the first dose of quinapril in patients with congestive heart failure.
    Squire IB; Macfadyen RJ; Lees KR; Hillis WS; Reid JL
    Br J Clin Pharmacol; 1994 Aug; 38(2):117-23. PubMed ID: 7981011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism by which quinapril improves vascular function in coronary artery disease.
    Koh KK; Bui MN; Hathaway L; Csako G; Waclawiw MA; Panza JA; Cannon RO
    Am J Cardiol; 1999 Feb; 83(3):327-31. PubMed ID: 10072217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Combined therapy with quinapril, an ACE inhibitor, and valsartan, a type 1 angiotensin II receptors blocker, for moderate chronic cardiac failure may raise the degree of neurohormonal block and improve 24-h heart rate variability compared to the effect of monotherapy (data from the trial SADKO-CHF)].
    Skvortsov AA; Nasonova SN; Sychev AV; Arbolishvili GN; Baklanova NA; Mareev VIu; Belenkov IuN
    Ter Arkh; 2005; 77(8):34-43. PubMed ID: 16206603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of chronic quinapril administration on heart rate variability in patients with diabetic autonomic neuropathy.
    Kontopoulos AG; Athyros VG; Didangelos TP; Papageorgiou AA; Avramidis MJ; Mayroudi MC; Karamitsos DT
    Diabetes Care; 1997 Mar; 20(3):355-61. PubMed ID: 9051387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The non-thiol angiotensin-converting enzyme inhibitor quinapril suppresses inflammatory arthritis.
    Dalbeth N; Edwards J; Fairchild S; Callan M; Hall FC
    Rheumatology (Oxford); 2005 Jan; 44(1):24-31. PubMed ID: 15353612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Albumin excretion rate and metabolic modifications in patients with essential hypertension. Effects of two angiotensin converting enzyme inhibitors.
    Puig JG; Mateos FA; Ramos TH; Lavilla MP; Capitán MC; Gil A
    Am J Hypertens; 1994 Jan; 7(1):46-51. PubMed ID: 8136110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multicentre, double-blind, placebo-controlled trial of quinapril in mild, chronic heart failure.
    Northridge DB; Rose E; Raftery ED; Lahiri A; Elder AT; Shaw TR; Henderson E; Dargie HJ
    Eur Heart J; 1993 Mar; 14(3):403-9. PubMed ID: 8458362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic effects of early started angiotensin converting enzyme inhibition and angiotensin AT1-receptor subtype blockade in rats with myocardial infarction: role of bradykinin.
    Hu K; Gaudron P; Anders HJ; Weidemann F; Turschner O; Nahrendorf M; Ertl G
    Cardiovasc Res; 1998 Aug; 39(2):401-12. PubMed ID: 9798525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of quinapril on functional status of elderly patients with diastolic heart failure.
    Zi M; Carmichael N; Lye M
    Cardiovasc Drugs Ther; 2003 Mar; 17(2):133-9. PubMed ID: 12975595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of angiotensin converting enzyme inhibition on myocardial function and blood pressure after coronary artery bypass surgery--a randomised study.
    Webb CM; Underwood R; Anagnostopoulos C; Bennett JG; Pepper J; Lincoln C; Collins P
    Eur J Cardiothorac Surg; 1998 Jan; 13(1):42-8. PubMed ID: 9504729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of quinapril on in-stent restenosis and relation to plasma apoptosis signaling molecules.
    Deftereos S; Giannopoulos G; Kossyvakis C; Kaoukis A; Raisakis K; Driva M; Panagopoulou V; Lappos S; Rentoukas I; Pyrgakis V; Alpert MA
    Am J Cardiol; 2010 Jan; 105(1):54-8. PubMed ID: 20102890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of amlodipine and quinapril on ambulatory blood pressure and platelet function in hypertension.
    Ding YA; Chang SM; Chou TC
    J Hum Hypertens; 1995 Aug; 9(8):637-41. PubMed ID: 8523379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of selective AT1-receptor blockade versus ACE inhibition for restenosis prophylaxis in patients with peripheral occlusive arterial disease after stent angioplasty: a randomized, controlled, proof-of-concept study.
    Schindler C; Mueller A; Bramlage P; Boecking W; Kirch W; Schweizer J
    Angiology; 2007 Dec-2008 Jan; 58(6):710-6. PubMed ID: 17928625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of quinapril on the attenuated heart rate recovery of type 2 diabetic subjects without known coronary artery disease.
    Sipahi I; Tekin G; Yigit Z; Guzelsoy D; Guven O
    Clin Cardiol; 2004 Aug; 27(8):480-4. PubMed ID: 15346847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quinapril: a further update of its pharmacology and therapeutic use in cardiovascular disorders.
    Culy CR; Jarvis B
    Drugs; 2002; 62(2):339-85. PubMed ID: 11817979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical pharmacology of quinapril in healthy volunteers and in patients with hypertension and congestive heart failure.
    Sedman AJ; Posvar E
    Angiology; 1989 Apr; 40(4 Pt 2):360-9. PubMed ID: 2539762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.